Abstract
Background
Osteoporosis, also called the silent disease, affects the elderly with a significant contribution to their morbidity and mortality through fragility fractures. Most nations have developed their own guidelines on managing this condition. Clinical Practice Guidelines (CPGs) are the highest quality evidence documents on a particular topic prepared by expert panels. CPGs offer standardised recommendations on a particular topic.
Methods
We looked at the CPGs of nations in the last five years and present the results of this review here. This review is divided into Risk assessment, prevention, diagnosis, Non pharmacological and pharmacological management with information from major CPGs only.
Results
Most CPGs agree on the broad principles of assessment , core risk factors, prevention and management with some finer differences in subtle aspects of assessment and management. There are differences in the use of screening tools based on the population numbers and affordability between nations. FRAX has been advocated for the screening with or without DEXA. Most CPGs use DEXA for confirmation of diagnosis. Intervention is based on FRAX scoring. Intervention thresholds vary. We discuss non-pharmacological management included diet and nutrition, calcium and Vitamin D, Exercise and physiotherapy, lifestyle changes and falls prevention. Pharmacological management included aspects of using different medications and their indications. The key agents recommended include Bisphosphonates, Teriparatide, Denosumab, SERMs, Hormone Replacement Therapy, and other agents including any drug holidays and duration of therapy.
Conclusions
This review identified some key recommendations from CPGs from multiple nations in each of the above given aspects of osteoporosis.
Similar content being viewed by others
References
WHO study Group. (1994). WHO technical Report Series: Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. World Health Organization.
What is osteoporosis and what causes it? Bone Health & Osteoporosis Foundation. (2023). https://www.bonehealthandosteoporosis.org/patients/what-is-osteoporosis/. Accessed 5 May 2023
Cooper, C., Campion, G., & Melton, L. J. (1992). Hip fractures in the elderly: A world-wide projection. Osteoporosis International, 2(6), 285–289. https://doi.org/10.1007/BF01623184
Kanis, J. A., Cooper, C., Rizzoli, R., Reginster, J. Y., on behalf of the Scientific Advisory Board of the European Society for Clinical and Economic Aspects of Osteoporosis (ESCEO) and the Committees of Scientific Advisors and National Societies of the International Osteoporosis Foundation (IOF). (2019). European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporosis International., 30(1), 3–44. https://doi.org/10.1007/s00198-018-4704-5
Kanis, J. A., Harvey, N. C., The Advisory Board of the National Osteoporosis Guideline Group, et al. (2016). A systematic review of intervention thresholds based on FRAX: A report prepared for the National Osteoporosis Guideline Group and the International Osteoporosis Foundation. Archives Osteoporosis, 11(1), 25. https://doi.org/10.1007/s11657-016-0278-z
Gregson, C. L., Armstrong, D. J., Bowden, J., et al. (2022). UK clinical guideline for the prevention and treatment of osteoporosis. Archives of Osteoporosis, 17(1), 58. https://doi.org/10.1007/s11657-022-01061-5
New Zealand Clinical Guidance | Osteoporosis. (2023). https://osteoporosis.org.nz/clinical-guidance/. Accessed June 26, 2023
Agency for Care Effectiveness, Singapore. Appropriate Care Guide: Osteoporosis Identification and management in primary care. (2018). www.ace-hta.gov.sg. Accessed June 2023
Chakhtoura, M., Leslie, W. D., McClung, M., Cheung, A. M., & Fuleihan, G. E. H. (2017). The FRAX-based Lebanese osteoporosis treatment guidelines: Rationale for a hybrid model. Osteoporosis International, 28(1), 127–137. https://doi.org/10.1007/s00198-016-3766-5
Lekamwasam, S., Adachi, J. D., Agnusdei, D., et al. (2012). A framework for the development of guidelines for the management of glucocorticoid-induced osteoporosis. Osteoporosis International, 23(9), 2257–2276. https://doi.org/10.1007/s00198-012-1958-1
Tarantino, U., Iolascon, G., Cianferotti, L., et al. (2017). Clinical guidelines for the prevention and treatment of osteoporosis: Summary statements and recommendations from the Italian Society for Orthopaedics and Traumatology. Journal of Orthopaedics and Traumatology, 18(S1), 3–36. https://doi.org/10.1007/s10195-017-0474-7
Trémollieres, F. A., Chabbert-Buffet, N., Plu-Bureau, G., et al. (2022). Management of postmenopausal women: Collège National des Gynécologues et Obstétriciens Français (CNGOF) and Groupe d’Etude sur la Ménopause et le Vieillissement (GEMVi) Clinical Practice Guidelines. Maturitas, 163, 62–81. https://doi.org/10.1016/j.maturitas.2022.05.008
Kirazlı, Y., Atamaz Çalış, F., El, Ö., et al. (2020). Updated approach for the management of osteoporosis in Turkey: A consensus report. Archives of Osteoporosis, 15(1), 137. https://doi.org/10.1007/s11657-020-00799-0
Meeta, M., & Tandon, V. (2020). Evidence-based clinical practice guidelines on menopause and postmenopausal osteoporosis (2019–2020): A step toward implementation of menopausal medicine. J Midlife Health., 11(2), 51–52. https://doi.org/10.4103/jmh.JMH_136_20
Weaver, C. M., Gordon, C. M., Janz, K. F., et al. (2016). The National Osteoporosis Foundation’s position statement on peak bone mass development and lifestyle factors: A systematic review and implementation recommendations. Osteoporosis International, 27(4), 1281–1386. https://doi.org/10.1007/s00198-015-3440-3
Meeta, M., Harinarayan, C., Marwah, R., Sahay, R., Kalra, S., & Babhulkar, S. (2020). Clinical practice guidelines on postmenopausal osteoporosis: *An executive summary and recommendations—Update 2019–2020. Journal of Mid-life Health, 11(2), 96. https://doi.org/10.4103/jmh.JMH_143_20
Camacho, P. M., Petak, S. M., Binkley, N., et al. (2020). American Association of Clinical Endocrinologists/American College of Endocrinology Clinical Practice Guidelines for the diagnosis and treatment of postmenopausal osteoporosis—2020 update executive summary. Endocrine Practice, 26(5), 564–570. https://doi.org/10.4158/GL-2020-0524
Tai, T. W., Huang, C. F., Huang, H. K., et al. (2022). Clinical practice guidelines for the prevention and treatment of osteoporosis in Taiwan: 2022 update. Journal of the Formosan Medical Association. https://doi.org/10.1016/j.jfma.2023.01.007
Lee, Y. A., Kwon, A., Kim, J. H., et al. (2022). Clinical practice guidelines for optimizing bone health in Korean children and adolescents. Ann Pediatr Endocrinol Metab., 27(1), 5–14. https://doi.org/10.6065/apem.2244060.030
Montero-Odasso, M. M., Kamkar, N., Pieruccini-Faria, F., et al. (2021). Evaluation of clinical practice guidelines on fall prevention and management for older adults: A systematic review. JAMA Network Open, 4(12), e2138911. https://doi.org/10.1001/jamanetworkopen.2021.38911
Montero-Odasso, M., Van Der Velde, N., Martin, F. C., et al. (2022). World guidelines for falls prevention and management for older adults: a global initiative. Age and Ageing., 51(9), afac205. https://doi.org/10.1093/ageing/afac205
Riancho, J. A., Peris, P., González-Macías, J., Pérez-Castrillón, J. L., SEIOMM Osteoporosis Guidelines Writing Group. (2022). Executive summary clinical practice guideline of postmenopausal, glucocortcioid-induced and male osteoporosis (2022 update). Spanish Society for Bone and Mineral Metabolism Investigation (SEIOMM). Rev Clin Esp (Barc)., 222(7), 432–439. https://doi.org/10.1016/j.rceng.2021.12.008
Evenepoel, P., Cunningham, J., Ferrari, S., et al. (2021). European Consensus Statement on the diagnosis and management of osteoporosis in chronic kidney disease stages G4–G5D. Nephrology Dialysis Transplantation., 36(1), 42–59. https://doi.org/10.1093/ndt/gfaa192
El Miedany, Y., Paruk, F., Kalla, A., et al. (2021). Consensus evidence-based clinical practice guidelines for the diagnosis and treat-to-target management of osteoporosis in Africa: An initiative by the African Society of Bone Health and Metabolic Bone Diseases. Archives of Osteoporosis, 16(1), 176. https://doi.org/10.1007/s11657-021-01035-z
El Miedany, Y., Abu-Zaid, M. H., El Gaafary, M., et al. (2021). Egyptian consensus on treat-to-target approach for osteoporosis: A clinical practice guideline from the Egyptian Academy of bone health and metabolic bone diseases. Egyptian Rheumatology and Rehabilitation., 48(1), 5. https://doi.org/10.1186/s43166-020-00056-9
Scottish Intercollegiate Guidelines Network. (2021). Management of osteoporosis and the prevention of fragility fractures: a national clinical guideline. Heallthcare Improvement Scotland.
Compston, J., Cooper, A., Cooper, C., et al. (2017). UK clinical guideline for the prevention and treatment of osteoporosis. Archives of Osteoporosis, 12(1), 43. https://doi.org/10.1007/s11657-017-0324-5
Eastell, R., Rosen, C. J., Black, D. M., Cheung, A. M., Murad, M. H., & Shoback, D. (2019). Pharmacological management of osteoporosis in postmenopausal women: An Endocrine Society* clinical practice guideline. Journal of Clinical Endocrinology and Metabolism, 104(5), 1595–1622. https://doi.org/10.1210/jc.2019-00221
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical standard statement
This article does not contain any studies with human or animal subjects performed by the any of the authors.
Informed consent
For this type of study informed consent is not required.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Poduval, M., Kambhampati, S.B.S. & Vishwanathan, K. A Review of Various Clinical Practice Guidelines on Osteoporosis in the Last 5 Years. JOIO 57 (Suppl 1), 7–24 (2023). https://doi.org/10.1007/s43465-023-01031-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s43465-023-01031-0